These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 11951573

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Propionibacterium acnes lipase in seborrheic dermatitis and other skin diseases and Unsei-in.
    Higaki S, Morohashi M.
    Drugs Exp Clin Res; 2003; 29(4):157-9. PubMed ID: 15018307
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Anti-lipase activity of Kampo formulations, coptidis rhizoma and its alkaloids against Propionibacterium acnes.
    Higaki S, Nakamura M, Morohashi M, Hasegawa Y, Yamagishi T.
    J Dermatol; 1996 May; 23(5):310-4. PubMed ID: 8675819
    [Abstract] [Full Text] [Related]

  • 7. Effects of pH on biomass, maximum specific growth rate and extracellular enzyme production by three species of cutaneous propionibacteria grown in continuous culture.
    Greenman J, Holland KT, Cunliffe WJ.
    J Gen Microbiol; 1983 May; 129(5):1301-7. PubMed ID: 6311940
    [Abstract] [Full Text] [Related]

  • 8. Incidence and lipolytic activity of Propionibacterium acnes (Corynebacterium acnes group I) and P. granulosum (C. acnes group II) in acne and in normal skin.
    Whiteside JA, Voss JG.
    J Invest Dermatol; 1973 Feb; 60(2):94-7. PubMed ID: 4266325
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of Propionibacterium acnes lipase activity by the antifungal agent ketoconazole.
    Unno M, Cho O, Sugita T.
    Microbiol Immunol; 2017 Jan; 61(1):42-44. PubMed ID: 28111792
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Minocycline effectively reduces acid producted by Propionibacterium granulosum.
    Higaki S, Kitagawa T, Morohashi M, Yamagishi T.
    J Dermatol; 2002 Jan; 29(1):20-2. PubMed ID: 11837569
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Differential susceptibility of Propionibacterium acnes, P. granulosum and P. avidum to free fatty acids.
    Ko HL, Heczko PB, Pulverer G.
    J Invest Dermatol; 1978 Dec; 71(6):363-5. PubMed ID: 722112
    [Abstract] [Full Text] [Related]

  • 16. Correlation between Propionibacterium acnes biotypes, lipase activity and rash degree in acne patients.
    Higaki S, Kitagawa T, Kagoura M, Morohashi M, Yamagishi T.
    J Dermatol; 2000 Aug; 27(8):519-22. PubMed ID: 10989576
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.